期刊文献+

应重视内镜操作期间抗血小板药物的管理 被引量:3

原文传递
导出
摘要 抗血小板药物(antiplateletagents,APA)主要包括阿司匹林和噻吩并吡啶类药物(氯吡格雷)等,近年来在心脑血管疾病领域中的应用较为广泛。内镜操作期问如何对这些药物进行管理成为广大内镜医师经常需要面临的一个重要临床问题。最近,欧洲消化内镜协会就目前内镜操作期间APA的管理进行了建议分级和循证推荐…。就内镜操作而言,根据操作所引起出血风险的不同,可分为低风险操作和高风险操作。目前,对APA的管理主要还是基于操作本身出血的风险以及停药后血栓形成的风险进行综合评价。
作者 王邦茂
出处 《中华消化内镜杂志》 2012年第1期4-5,共2页 Chinese Journal of Digestive Endoscopy
  • 相关文献

参考文献3

二级参考文献65

  • 1马娟,元刚,陈旻湖.非甾体类消炎药对胃黏膜的损伤及替普瑞酮预防作用的实验研究[J].中华医学杂志,2006,86(40):2868-2873. 被引量:12
  • 2吕树铮,宋现涛,陈韵岱,陈欣,中国经皮冠状动脉介入治疗登记调查研究协作组.中国大陆2005年度经皮冠状动脉介入治疗登记调查研究结果初步分析[J].中华心血管病杂志,2006,34(11):966-970. 被引量:43
  • 3栾好波.非甾体类抗炎药物对胃肠道损伤机制及预防[J].齐鲁药事,2007,26(5):297-299. 被引量:8
  • 4Serebruany VL,Steinhubi SR,Berger PB,et al.Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials.Am J Cardio1,2005,95:1218-1222.
  • 5Walker J,Robinson J,Stewart J,et al.Does enteric-ccated aspirin result in a lower incidence of gastrointestinal complications compared to normal aspirin? Interact Cardiovasc Thorac Stag,2007,6:519-522.
  • 6Kelly JP,Kanfman DW,Jurgelon JM,et al.Risk of aspirinassociated major upper-gastrointestinal bleeding with enteric-coated or buffered product.Lancet,1996,348:1413-1416.
  • 7Hemandez-Diaz S,Garcia Rodriguez LA.Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications.BMC Med,2006,4:22.
  • 8Taha AS,Angerson WJ,Prnsad R,et al.Clinical trial:the incidence and early mortality after peptic ulcer perforation,and the use of low-dose aspirin and nonsteroidal anti-inflammatory drugs.Aliment Pharmacol Ther,2008,28:878-885.
  • 9Papatheodoridis GV,Sougioultzis S,Archimandrifis AJ.Effcts of Helicobacter pylori and nonsteroidal anti-inflammatery drugs on peptic ulcer disease:a systematic review.Clin Gastroenterol Hepatol,2006,4:130-142.
  • 10Huang JQ,Sridhar S,Hunt RH.Role of Helicobacter pylori infection and non-steroidal anti-infammatury drugs in peptic-ulcer disease:a meta-analysis.Lancet,2002,359:14-22.

共引文献166

同被引文献72

  • 1朱东,李欣欣,刘小方.老年人大肠巨大息肉内镜下治疗分析[J].中华消化内镜杂志,2006,23(6):467-469. 被引量:4
  • 2Hirsh J, Guyatt G, Albers GW, et al. Antithrombotic and throm- bolytic therapy: American College of Chest PhysiciansEvidence- Based Clinical Practice Guidelines (8th Edition). Chest, 2008, 133 :Sl10-Sl12.
  • 3Anderson MA, Ben-Menachem T, Gan SI, et al. Management of antithrombotic agents for endoscopic procedures. Gastrointest En- dosc, 2009,70 : 1060-1070.
  • 4Gerson LB, Gage BF, Owens DK, et al. Effect and outcomes of the ASGE guidelines on the periendoscopic management ofpa- tients who take anticoagulants. Am J Gastroenterol, 2000,95: 1717-1724.
  • 5Shiffman ML, Farrel MT, Yee YS. Risk of bleeding after endo- scopic biopsy or polypectomy in patients takingaspirin or other NSAIDS. Gastrointest Endosc, 1994,40:458-462.
  • 6Hui A J, Wong RM, Ching JY, et al. Risk of colonoscopic polypectomy bleeding with anticoagulants and antiplateletagents: analysis of 1657 cases. Gastrointest Endose, 2004,59:44-48.
  • 7Sawhney MS, Salfiti N, Nelson DB, et al. Risk factors for severe delayed postpolypectomy bleeding. Endoscopy, 2008, 40 : 115-119.
  • 8Hui CK, Lai KC, Yuen MF, et al. Does withholding aspirin for one week reduce the risk of post-sphincterotomybleeding. Aliment Pharmacol Ther, 2002,16:929-936.
  • 9Friedland S, Soetikno R. Colonoscopy with polypectomy in anti- coagulated patients. Gastrointest Endosc, 2006,64:98-100.
  • 10Hussain N, Alsulaiman R, Burtin P, et al. The safety of endo- scopic sphincterotomy in patients receiving antiplateletagents: a case-control study. Aliment Pharmacol Ther, 2007,25:579-584.

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部